Elevated levels of the oncoprotein, osteopontin (OPN), are associated with poor outcome of several types of cancers including melanoma. We have previously reported an important involvement of DNAJB6, a member of heatshock protein 40 (HSP40) family, in negatively impacting tumor growth. The current study was prompted by our observations reported here which revealed a reciprocal relationship between DNAJB6 and OPN in melanoma specimens. The 'J domain' is the most conserved domain of HSP40 family of proteins. Hence, we assessed the functional role of the J domain in activities of DNAJB6. We report that the J domain of DNAJB6 is involved in mediating OPN suppression. Deletion of the J domain renders DNAJB6 incapable of impeding malignancy and suppressing OPN. Our mechanistic investigations reveal that DNAJB6 binds HSPA8 (heat-shock cognate protein, HSC70) and causes dephosphorylation of glycogen synthase kinase 3b (GSK3b) at Ser 9 by recruiting protein phosphatase, PP2A. This dephosphorylation activates GSK3b, leading to degradation of b-catenin and subsequent loss of TCF/LEF (T cell factor1/lymphoid enhancer factor1) activity. Deletion of the J domain abrogates assembly of this multiprotein complex and renders GSK3b inactive, thus, stabilizing b-catenin, a transcription coactivator for OPN expression. Our in-vitro and in-vivo functional analyses show that silencing OPN expression in the background of deletion of the J domain renders the resultant tumor cells less malignant despite the presence of stabilized b-catenin. Thus, we have uncovered a new mechanism for regulation of GSK3b activity leading to inhibition of Wnt/b-catenin signaling.
Introduction
The human genome codes for more than 40 distinct heat-shock protein 40 (HSP40) (DNAJ) members . A typical DNAJ protein is characterized by a J domain, a glycine-Phenylalanine (G/F) domain and a C-terminal domain. Depending on the presence of these domains, this family is divided into Type I, Type II and Type III (also known as DNAJ A, B and C) types (Ohtsuka and Hata, 2000) . The J domain consists of highly conserved Histidine-Proline-Aspartic acid (HPD) tri-peptide and, is the most conserved domain of this family and has been implicated in providing the substrate specificity to the individual members (Kelley, 1998) . The importance of this family in critical biological activities has been highlighted in the recent past (Edwards and Munger, 2004; Tsai et al., 2006; Dhennin-Duthille et al., 2011) . Noteworthy among them are the recruitment of HSP70, participation in guiding misfolded proteins to degradation, cell-cycle control and regulation of protein kinases (Kelley, 1998; Vos et al., 2008; Kampinga and Craig, 2010) . DNAJB6, the focus of this study, has been reported to reduce protein aggregates in Huntington's, Parkinson's diseases, placental development and neural stem cells (Hunter et al., 1999; Chuang et al., 2002; Dai et al., 2005; Watson et al., 2007 Watson et al., , 2009 Zhang et al., 2008; Dey et al., 2009) . We have previously demonstrated the role of DNAJB6 in reducing tumorigenicity and metastatic potential . Our studies have also shown that DNAJB6 can cause reversal of epithelial-mesenchymal transition (EMT) by inhibiting Wnt/b-catenin signaling (Mitra et al., 2010) .
Melanoma is a highly invasive and metastatic type of skin cancer. Cure rates drop precipitously once it has metastasized. Many distinct signaling mechanisms involving molecules such as b-Raf, AKT, P16 and P53 have been implicated to be involved in melanoma progression (Rodolfo et al., 2004; Lopez-Bergami et al., 2008; Martin et al., 2009) . Osteopontin (OPN) , is an RGD domain-containing SIBLING family glycoprotein that has diverse roles in promoting malignancy of a multiple tumor types and is advocated to be involved in melanoma progression and metastasis (Buback et al., 2009; Shevde et al., 2010) . We have previously shown that OPN expression is increased with progression and gain of metastatic potential by melanomas (Riker et al., 2008; Metge et al., 2010) . OPN has been implicated to be involved in promoting immune evasion by tumor cells, in EMT and in inhibiting apoptosis (Wai and Kuo, 2004; Chakraborty et al., 2006; Alonso et al., 2007; Saika et al., 2007; Tuck et al., 2007; Chiodoni et al., 2010) . Elevated levels of OPN are associated with poor outcome in a variety of cancers such as breast cancer, mesothelioma, colon cancer and ovarian cancer (Furger et al., 2001; Yeatman and Chambers, 2003; Greillier et al., 2008; Shih Ie and Davidson, 2009) . In this study, we assessed DNAJB6 and OPN expression from melanoma specimens and found an inverse relationship between the transcript levels of these two genes. Here, we present that the J domain of DNAJB6 has a critical role in mediating its activity. Specifically, the interaction of DNAJB6 with HSPA8 (heat-shock cognate protein, HSC70) is mediated via the J domain and is responsible for the protein phosphatase 2 (PP2A)-driven dephosphorylation of glycogen synthase kinase 3b (GSK3b) at Serine 9. This dephosphorylation activates GSK3b causing downregulation of TCF/LEF (T cell factor1/lymphoid enhancer factor1) signaling leading to reduced OPN expression. We demonstrate that this downregulation is one of the important mechanisms of DNAJB6-mediated inhibition of malignancy.
Results
Loss of DNAJB6 in aggressive melanoma is inversely related with gain of OPN Elevated levels of OPN in tumor tissue and serum are associated with increased invasion and metastasis of melanoma (Denhardt, 2005; Buback et al., 2009) . We had previously noted a possible negative regulatory effect of DNAJB6 on OPN transcript levels . To directly test the clinical relevance of this observation in melanoma, we assessed DNAJB6 and OPN expression from melanoma specimens and found that OPN expression was significantly upregulated in stage III and IV metastatic melanomas ( Figure 1a ) and in the same set of samples, DNAJB6 expression was compromised (Figure 1b) . Of those tumor specimens that expressed lower DNAJB6 than normal controls, about 70% expressed higher OPN than normal controls (exact binomial test, P ¼ 0.0032). These observations strongly imply an inverse relationship between expression of DNAJB6 and OPN in metastatic melanomas and prompted us to study the mechanism of regulation of OPN by DNAJB6. Independently, estimation of cellular levels of DNAJB6 and OPN from a panel of melanoma cells with increasing malignant potential in comparison with normal human epidermal melanocytes revealed an inverse pattern of expression and corroborated with observations made from melanoma specimens (Supplementary Figure 1) .
The J domain of DNAJB6 is involved in mediating OPN suppression The J domain of HSP40 proteins is critical in mediating many of their known functions. To investigate if the J domain of DNAJB6 has a role in regulating OPN, we generated two mutant DNAJB6 cDNA constructs. One capable of coding for DNAJB6 devoid of the J domain (referred to as DJ) and the other that introduced mutations in the most conserved HPD tri-peptide of the J domain, changing them to three alanines (AAA; referred to as HPD MUT ) ( Figure 2 , schematic of DNAJB6). Serum-free conditioned media from the stable expressors of wild-type DNAJB6 in MDA-MB-435 cells (435-DNAJB6), the corresponding vector control (435-V), 435-DNAJB6-DJ or 435-DNAJB6-HPD MUT were assessed for OPN levels. While serumfree conditioned media from 435-V showed copious amounts of OPN, OPN was undetectable in 435-DNAJB6. However, 435-DNAJB6-DJ and 435-DNAJB6-HPD MUT showed higher levels of OPN, suggesting that the ability (Figure 2c ). In the A375 cells, there was about 75% reduction in the OPN transcript levels in DNAJB6 expressers; this was relieved by J domain deletion and HPD mutation (Figure 2d) . Furthermore, the evaluation of activity of OPN promoter using luciferase reporter assay showed 50% suppression when co-transfected with DNAJB6 compared with the empty vector control. However, DNAJB6-DJ was unable to suppress OPN promoter activity (Supplementary Figure 2) . These results indicate the critical involvement of the J domain of DNAJB6 in mediating suppression of OPN.
The J domain is involved in mediating reversal of EMT by DNAJB6 OPN is a pro-malignancy factor and we found that the J domain is largely responsible for regulating OPN; hence, we speculated that the J domain of DNAJB6 may have a critical role in mediating its anti-malignant functions. The phenomenon of EMT is closely linked with invasion and metastasis. Since one of the known functions of DNAJB6 is to suppress the mesenchymal phenotype, we evaluated the impact of deletion of the J domain on the ability of DNAJB6 to regulate the mesenchymal phenotype. Expression of DNAJB6 in mesenchymallike MDA-MB-435 cells changed the appearance of these cells in 2D culture from spindle (lanceolate)-shaped cells to cells with more compact, cobblestonelike morphology. However, 435-DNAJB6-DJ cells and 435-DNAJB6-HPD MUT cells did not show any noticeable change in 2D morphology (Figure 3a) .
The same sets of cells were evaluated for morphology in three-dimensional (3D) growth. Cells that have undergone EMT are known to exhibit an invasive phenotype in 3D matrix. These cells show invadopodia and invade away from the central spherical growth. The vector-only expressing cells and 435-DNAJB6-DJ cells and 435-DNAJB6-HPD MUT showed highly invasive outgrowths in 3D culture. However, the 435-DNAJB6 cells maintained a compact spherical growth pattern resembling a more epithelial-like behavior (Figure 3a) . The observations made for A375 melanoma cells and their DNAJB6 and DJ expressors for 3D growth corroborate these results (Supplementary Figure 3a) .
Based on these clear morphological differences, we evaluated mRNA expression of Keratin 18 (KRT18) as an epithelial marker and vimentin as a mesenchymal marker. These markers did not show noticeable changes; the levels of mesenchymal transcription factor SLUG also remained unaltered. However, there was a consistent, dramatic upregulation (Po0.001) in the expression of mesenchymal transcription factor, TWIST in To test if the mesenchymal-like phenotype was due to the inability to suppress OPN, we stably silenced OPN from 435-DNAJB6-DJ cells using shRNA NM-636 (Shevde et al., 2006) to generate DNAJB6-DJ-OPNi cells. Unlike the highly invasive nature of 435-DNAJB6-DJ observed in 3D culture, the DNAJB6-DJ-OPNi cells showed a compact spherical growth pattern resembling a more epithelial-like behavior (Figure 3a) , with noticeable downregulation of TWIST transcript and a concomitant upregulation of KRT18 transcript (Supplementary Figure 3b) . The involvement of OPN was further confirmed by our observation that the DNAJB6-DJ-OPNi cells show highly invasive growth in 3D upon addition of exogenous OPN, which phenocopies the change in 3D morphology observed for 435-DNAJB6 upon exogenous addition of OPN ( Figure 3a) .
Hence, we further evaluated the role of the J domain in regulation of malignant properties by DNAJB6 by a series of in-vitro and in-vivo assays.
The J domain is critical for restriction of attributes of malignancy by DNAJB6 To assess the contribution of the J domain on the ability of DNAJB6 to restrict malignant behavior in vitro, we compared the anchorage-independent growth (soft agar colony formation assay) of 435-DNAJB6-DJ and 435-DNAJB6 with 435-V. While 435-DNAJB6 showed about 40% suppression of colony formation, this attribute was lost upon deletion of the J domain ( Figure 4a ). However, DNAJB6-DJ-OPNi cells showed suppression of colony formation comparable to 435-DNAJB6 transfected with a scrambled control, further attesting the importance of OPN regulation downstream of DNAJB6 (Supplementary Figure 4a) .
We tested the in-vivo attributes of malignancy by evaluating the growth of these cells as xenografts in athymic mice. 435-V, 435-DNAJB6-DJ and 435-DNAJB6-HPD MUT show a rapid tumor take rate. All animals in these groups showed tumors at day 7 and a rapid tumor growth thereafter. The 435-DNAJB6 tumors were slow to pick up and exhibited limited growth (Po0.001) ( Figure 4b ); this strongly supports our contention that the J domain of DNAJB6 is important for its negative impact on tumor growth. EMT is implied to have a role in affecting invasion and metastasis. MUT expressors of MDA-MB-435 were analyzed for their cell shape in adherent culture on tissue culture plastic (2D) (column 1) or 3D morphology in 3D Culture Matrix Basement Membrane Extract (3D) (column 2). Arrows indicate invasive growth in the 3D matrix. Simultaneously, 3D morphology of DNAJB6 expressors cultured in media supplemented with 100 ng/ml human recombinant OPN was evaluated (column 3, row 2). 3D growth of DNAJB6-DJ cells silenced for OPN expression (DNAJB6-DJ-OPNi) was compared with the same cells cultured in media supplemented with 100 ng/ml human recombinant OPN (columns 3 and 4, row 3). Experiments were performed in triplicate and repeated once. Scale bars correspond to 100 mM. (b) DNAJB6, DNAJB6-DJ and DNAJB6-HPD MUT expressors of MDA-MB-435 were analyzed for mRNA levels for epithelial marker KRT18, mesenchymal markers vimentin, SLUG and TWIST using qRT-PCR. The readings show the fold change in expression with respect to the DNAJB6 expressors. The Y axis is in log 10 scale. *Indicates statistically significant differences.
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MUT cells shows that there is no statistically significant difference in the metastasis. When similarly tested, the DNAJB6-DJ-OPNi cells showed suppressed tumor growth and pulmonary metastasis compared with the scrambled control ( Supplementary Figures 4b-d) . These compelling results prompted us to explore the molecular mechanism of J domain-dependent regulation of OPN. OPN has been reported to be a transcription target of b-catenin (TCF/LEF) transcription (El-Tanani et al., 2001) . Hence, we evaluated effects of the J domain deletion on Wnt/b-catenin signaling.
Deletion of J domain upregulates TCF/LEF activity and renders DNAJB6 incapable of dephosphorylating GSK3b
We assessed the levels of b-catenin in 435-DNAJB6 and 435-DNAJB6-DJ. We found that 435-DNAJB6 did not show detectable levels of b-catenin. However, 435-DNAJB6-DJ showed levels of b-catenin comparable to 435-V (Figure 5a ). DNAJB6 significantly downregulates the b-catenin-dependent signaling through TCF/LEF transcription factors (Mitra et al., 2010) . To test if the J domain has a role in this activity, we assessed the luciferase reporter activity of the TOPFlash reporter (consisting of seven tandem TCF/LEF binding sites) in 435-DNAJB6, 435-DNAJB6-DJ and 435-V. The results showed that 435-DNAJB6 suppressed the TCF/LEF activity by about 50%; however, DNAJB6-DJ failed to exhibit such suppression (Figure 5b) . Similarly in A375, DNAJB6 expressors showed very low levels of b-catenin, in contrast to levels of b-catenin that were unaltered in A375-DNAJB6-DJ relative to the vector control cells (Figure 5c ). Correspondingly, unlike the DNAJB6 expressors, A375-DNAJB6-DJ lacked the ability to suppress the TCF/LEF transcription ( Figure 5d ).
It is well documented that phosphorylation of bcatenin by GSK3b targets it for degradation (Behrens et al., 1998; Hinoi et al., 2000) . However, phosphorylation of GSK3b itself at Ser 9 residue (P-Ser 9-GSK3b) dictates its activity; the dephosphorylated form is the active form responsible for phosphorylation of b-catenin (Miller and Moon, 1996; Orford et al., 1997) . Western blot analysis showed that P-GSK3b-Ser 9 levels were undetectable in DNAJB6 expressors of 435 and A375 relative to the vector. However, DNAJB6-DJ expressors showed P-GSK3b-Ser 9 levels, which are comparable to the respective vector controls. Levels of total GSK3b were unaltered (Figures 5a and b) . These observations indicate that DNAJB6 expression causes dephosphorylation of Ser 9 of GSK3b, and the J domain is essential for mediating this activity.
DNAJB6 interacts with HSPA8
To get more insight into the mechanism by which DNAJB6 regulates the phosphorylation status of GSK3b, we performed a mass-spectrometric analysis of the co-immunoprecipitated proteins from 435-DNAJB6 expressing cells. The results revealed HSPA8 (HSC70) as an interactor of DNAJB6 and it was absent in co-immunoprecipitate from DNAJB6-DJ expressing (c) To evaluate metastatic ability, primary tumors were surgically removed by survival surgery under anesthesia. After 7 weeks, mice were euthanized and lung metastases were counted. *Indicates statistically significant differences.
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A Mitra et al cells ( Supplementary Figures 5a and b) . To confirm this result, we transiently co-expressed cDNAs of HSPA8 with HA epitope-tagged DNAJB6 and DNAJB6-DJ in COS7 cells. Immunoprecipitation was performed using anti-HA antibody and was analyzed by western blot for the presence of HSPA8. The results demonstrated that DNAJB6 was able to co-immunoprecipitate HSPA8; however, DNAJB6-DJ failed to bind HSPA8 (Figure 6a ). The DNAJB6-HSPA8 interaction was also confirmed using mammalian two-hybrid system. DNAJB6 interacted with HSPA8 resulting in about sixfold activation in the pGL4.31-luciferase reporter activity; however, DNAJB6-DJ failed to interact with HSPA8 as seen by lack of activation of the reporter (Figure 6b(I) ).
HSPA8 has been implicated to interact with PP2A (Polanowska-Grabowska et al., 1997; Whalen et al., 2005) . Hence, we hypothesized that DNAJB6-HSPA8-PP2A form a molecular complex that binds to and dephosphorylates GSK3b at Ser 9. We used size exclusion chromatography to separate multiprotein complexes. Western blot analysis of the eluted fractions revealed co-elution of DNAJB6-HSPA8-PP2A and GSK3b in fractions 13-15, which corresponded to approximate molecular weight range of 700-1000 kDa (Figure 6c) . Similarly, co-elution of DNAJB6, HSPA8, GSK3b and PP2A was detected in the melanoma cell line MCC013 (derived from primary tumor, which still retains noticeable DNAJB6 expression; Supplementary  Figure 6a) .
To confirm the interactions further, immunoprecipitation of PP2A and GSK3b was performed independently from the total protein of DNAJB6 expressors. As seen in Figure 6d , both PP2A and GSK3b could co-immunoprecipitate HSPA8. Independently, we also verified the interaction of GSK3b with DNAJB6 using mammalian two-hybrid system (Figure 6b(II) ). DNAJB6 interacted with GSK3b resulting in twofold increase in the pGL4.31-luciferase reporter activity. Similarly, HSPA8 interacted with GSK3b resulting in little over twofold increase in the reporter activity (Figure 6b(II) ). Additionally, silencing DNAJB6 expression from MCC013 cells resulted in elevated levels of P-GSK3b-Ser 9, which also reflected in elevated levels of b-catenin transcription target OPN (Supplementary Figure 6b) . Taken together, the results of the protein interaction studies indicate that DNAJB6 and HSPA8 complex chaperones interaction of PP2A and GSK3b.
Okadaic acid treatment renders DNAJB6 incapable of dephosphorylating GSK3b
Protein phosphatase 2 is a multimeric enzyme with structural subunit A, catalytic subunit B and regulatory subunit C. Each of the subunits is coded by multiple genes and hence there could be several PP2 holoenzymes (Sablina and Hahn, 2007; Eichhorn et al., 2009 ). Okadaic acid is a known inhibitor of protein phosphatase with a relatively high specificity toward PP2 (Fernandez et al., 2002) . To test if the reduction in PGSK3b-Ser 9 and subsequent degradation of b-catenin upon DNAJB6 expression was dependent on the phosphatase activity of PP2A, DNAJB6 expressing cells were treated with 20 nM okadaic acid (concentration relatively specific to PP2A) for 8 h duration. As seen in Figure 5 J domain is necessary for the negative impact of DNAJB6 on Wnt/b-catenin signaling. Expressors for DNAJB6 and DNAJB6-DJ were probed for levels of GSK3b, b-catenin and P-GSK3b-Ser 9 western blot analyses for (a) MDA-MB-435 and (b) A375. The levels were compared with respective vector-only controls. b-Actin was used as a loading control. TCF/LEF-driven transcription activity was measured as an indicator of Wnt/b-catenin signaling using TOPFlash luciferase reporter assay in DNAJB6, DNAJB6-DJ expressors of (c) MDA-MB-435 and (d) A375. The assay was performed in triplicate and repeated once. The luciferase activity readings were normalized with activity from a co-transfected b-gal expressing control. The error bars represent s.e.m. *Indicates statistically significant differences. Figure 7a , okadaic acid treatment resulted in increased expression of P-GSK3b-Ser 9 and b-catenin.
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Real-time PCR done with cDNA generated from okadaic acid-treated 435-DNAJB6 cells showed increased levels of OPN transcript but no change in b-catenin transcript (Figure 7b ). Cumulatively, these observations suggest that okadaic acid inhibition of PP2 activity led to increased P-Ser 9-GSK3b levels rendering it inactive. This increased the stability of b-catenin, which was reflected in the elevated b-catenin protein levels and is evident by a concomitant increase in OPN transcript levels. Additionally, silencing PP2A using siRNA in 435-DNAJB6 cells showed increased PGSK3b-Ser 9 with concomitant elevation in b-catenin protein levels as detected by western blot analysis. The involvement of PP2A was also more evident when siRNA silencing of PP1 (protein phosphatase 1) from the same cells failed to show any increase in b-catenin protein (Figure 7c) . A concomitant upregulation in TCF/LEF transcription in the PP2A silenced cells was evident as a twofold increase in the TOPFlash reporter activity (Figure 7d) . Cumulatively, these observations confirm the involvement of PP2A in removal of the phosphate from P-GSK3b-Ser 9 and converting it to the active form.
Discussion
Wnt/b-catenin signaling is a critical and highly regulated developmental pathway, which is equally important for cellular homeostasis. Aberrant activation of Wnt/bcatenin signaling can be oncogenic (Lucero et al., 2010) . Multiple reports document deregulation of the Wnt pathway in melanoma clinical specimens (Pecina-Slaus et al., 2007; Zuidervaart et al., 2007; Moore et al., 2008) . The Wnt pathway is intricately regulated by a complex interplay of a variety of Wnt ligands, receptors and secreted inhibitors leading to modulation of intracellular signaling components (Weeraratna, 2005) . Wnt ligands such as Wnt1 and Wnt3A signal via b-catenin to promote melanocyte differentiation and tumor development (O'Connell and Weeraratna, 2009) . Critical protein members of the Wnt/b-catenin pathway, such as adenomatous polyposis coli, ICAT, LEF1 and b-catenin are modified in melanomas leading to activation of this signaling (Larue and Delmas, 2006) . However, tumor microenvironment alterations of secreted inhibitors of Wnt pathway and complex interplay of canonical, noncanonical Wnt signaling results in context-dependent effects of Wnt pathway in cancers such as melanoma (Lucero et al., 2010; Menezes et al., 2011) .
The role of HSP40 family members in regulating a variety of cellular signaling is emerging. Notably, tumor suppressor hTid1 (DNAJA3) has been reported to be associated with adenomatous polyposis coli, together with a complex of HSP70, HSC70, Actin, Dvl and Axin in normal colon epithelium. This complex is not associated with adenomatous polyposis coli's involvement in b-catenin degradation; however, it is implicated in maintenance of the polarity of colonic epithelial cells (Kurzik-Dumke and Czaja, 2007; Kurzik-Dumke et al., . Htid1 is a Type I HSP40 protein whereas DNAJB6 belongs to another distinct type (Type II). The core J domain of the HSP40 family members has similarity but each of the members perform a distinct function . In this work, we have demonstrated that DNAJB6 significantly downregulates expression of the secreted oncoprotein, OPN. We also show that this activity of DNAJB6 is mediated through its J domain. Though J domains, with conserved HPD amino acid trio, are conserved throughout the HSP40 family of proteins the actual roles played by these domains for the respective HSP40 vary significantly and are dependent on the sequence that is flanking the HPD motif (Hennessy et al., 2005) . These domains bind to the specific member(s) of DNAK (HSP/HSC70) family of proteins and this association decides recruitment of appropriate client proteins for a variety of downstream processing or for targeting proteins to destruction (Fan et al., 2003; Kampinga and Craig, 2010) . Thus, the DNAJ family of proteins has a critical role in regulation of several critical cellular processes in association with HSP70 family of proteins (Qiu et al., 2006) . Our data show that DNAJB6 interacts with HSPA8, a constitutively expressed member of HSP/HSC70 family. We also demonstrate that the Ser 9 phosphorylation status of GSK3b is dependent on formation of this complex. GSK3b is a highly regulated kinase that regulates a critical signaling node of Wnt, Hedgehog and SNAIL signaling (Zhou and Hung, 2005; Wang et al., 2011) . Our work shows that DNAJB6 expression keeps GSK3b in an activated state by mediating Ser 9 dephosphorylation. DNAJB6 performs this task through its J domain. We also see that the J domain is involved in recruiting HSPA8. Hence, it is tempting to propose that by binding to HSPA8, DNAJB6 recruits PP2A and GSK3b to facilitate Ser 9 dephosphorylation of GSK3b.
OPN has been suggested to be a target of active Wnt/ b-catenin signaling (El-Tanani et al., 2006) . The role of OPN in modulation of the malignant properties of cancer cells is well established (Furger et al., 2001) . Results reported here by us and reports by others document that OPN expression is significantly elevated in melanomas (Riker et al., 2008; Das et al., 2009; Metge et al., 2010) . Our nude mice xenograft studies demonstrate that suppression of OPN is responsible for the reduced malignant attributes of DNAJB6 expressors. The Y axis is in log 10 scale. *Indicates statistically significant differences. (c) I: PP2A expression was silenced from 435-DNAJB6 expressors using siRNA transfection. Total protein (30 mg) was resolved using SDS-PAGE and probed for levels of PP2A, b-catenin and P-GSK3b-Ser 9. Levels of b-actin were determined to confirm comparable loading. II: PP1 expression was silenced from 435-DNAJB6 expressors using siRNA transfection. Total protein (30 mg) was resolved using SDS--PAGE and probed for levels of PP1, b-catenin. Levels of b-actin were determined to confirm comparable loading. (d) TOPFlash reporter activity was evaluated in 435-DNAJB6 expressors silenced for PP2A expression in comparison with the control siRNA. Experiment was performed in triplicate and repeated once. The error bars represent s.e.m. *Indicates statistically significant differences.
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The inverse relationship of DNAJB6 and OPN expression attests the relevance and importance of the described signaling in melanoma progression. Our molecular signaling observations uncover the mechanism behind this inverse relationship. We observed downregulation of DNAJB6 expression accompanying melanoma progression. DNAJB6 expression compromises stability of b-catenin and hence negatively regulates Wnt/b-catenin signaling. The OPN promoter consists of many regulatory elements, among which the TCF4/LEF1 has been reported to be binding partners of b-catenin. Our results using the TOPFlash reporter consisting of tandem TCF/LEF sites in a reporter vector along with full-length DNAJB6 or DNAJB6-DJ indicate the role of the J domain in repressing the TCF/LEF reporter activity. Mesenchymal phenotype has been implied as one of the major determinant of melanoma metastasis (Lin et al., 2010) . Based on a high-throughput study of 34 vertical growth phase melanoma patients with 36 months follow-up, EMT-related gene expression, including OPN has been reported to be significantly associated with metastasis development (Alonso et al., 2007) . Similarly, TWIST expression in melanoma cell line has been suggested to have a role in EMT (Kushiro and Nunez, 2011) . Several reports have implicated TWIST to be downstream target of Wnt signaling (Howe et al., 2003; Reinhold et al., 2006) . Our study has not directly explored the relationship between OPN and TWIST. However based on our results, it is reasonable to posit that both OPN and TWIST, proteins that contribute to mesenchymal-like phenotype, are downstream negatively regulated targets of DNAJB6 regulated Wnt/b-catenin signaling.
In summary, we propose that GSK3b is a client of DNAJB6-HSPA8 complex. This complex recruits PP2 activity and dephosphorylates GSK3b at Ser 9. The specificity and activity of PP2A are highly regulated and accumulating evidence indicates that PP2A acts as a tumor suppressor (Eichhorn et al., 2009) due to its involvement in regulation of a number of major signaling pathways, including Wnt, PI3K/Akt and c-Myc. However, direct substrates and intricate mechanistic details involved in modulation of these signaling pathways have yet to be identified for the specific PP2A complexes (Sablina et al., 2010) . The regulatory subunit of PP2A, B56, has been shown to interact with adenomatous polyposis coli and is implicated in reducing the abundance of b-catenin and in inhibition of transcription of b-catenin target genes (Seeling et al., 1999) . Independently, in Drosophila, it has been shown that the regulatory subunit of PP2A, PR55-a, controls b-catenin phosphorylation, degradation and hence the Wnt/b-catenin signaling (Zhang et al., 2009) . Our findings reinforce the overall contribution of PP2A in downregulating the Wnt/b-catenin signaling. However, we highlight a key role of the DNAJB6-HSPA8 complex in PP2A-dependent dephosphorylation of GSK3b, and thus define a novel mechanism for dephosphorylation of GSK3b and consequent regulation of Wnt signaling.
Materials and methods
Plasmids and constructs
Details of DNAJB6 expressors are described previously . DNAJB6-DJ was generated by deletion of the J domain (amino acids 2-70) using inverse PCR. DNAJB6-HPD MUT was generated by specifically mutating each of the HPD amino acids (#31-33) to alanine. TOPFlash is a TCF-LEF transcription activity luciferase reporter, which was generously gifted by Dr Randall Moon (Veeman et al., 2003) . Full-length DNA constructs for GSK3b and HSPA8 (Plasmid #14 753 and 19 541) were obtained from Addgene (Addgene Inc., Cambridge, MA, USA). DNAJB6, DNAJB6-DJ, DNAJB6-HPD MUT and HSPA8 were PCR amplified and cloned into pACT (XbaI/KpnI). GSK3b (PCR amplified) and HSPA8 were cloned into pBIND (XbaI/KpnI).
Details of cell culture and collection of serum-free media, immunoblotting, immunoprecipitation and soft agar colonization are described in Supplementary Material.
Mass spectrometry
The immunoprecipitates were run on an SDS-PAGE and stained with Coomassie blue (Bio-Rad, Hercules, CA, USA). The differentially stained bands were excised using a razor blade and the gel pieces were treated with trypsin. Electrospray tandem mass spectrometry was performed with a Q-TOF Ultima API mass spectrometer (Waters, Milford, MA, USA) equipped with a nanoflow electrospray. The resulting data files were searched using an in-house MASCOT search engine (version 2.1.03; Matrix Science Ltd, London, UK). Ion scores >35 (Po0.05) were considered significant. Only proteins matching at least two peptides in MASCOT were accepted.
RNA isolation and real-time qRT-PCR TRIzol reagent (Invitrogen, Carlsbad, CA, USA) was used to isolate total RNA from cultured cells. RNA was treated with DNase I (Promega Corp., Madison, WI, USA). cDNA synthesis was carried out using a cDNA synthesis kit (Applied Biosystems Inc., Foster City, CA, USA) with 1 mg total RNA as the template and random primers. Real-time qRT-PCR analysis was performed on the experimental mRNAs. The PCR primers and probes for DNAJB6, c-Myc, SPP1(OPN), Twist, SLUG, KRT18, Vimentin and endorse control gene glyceraldehyde 3-phosphate dehydrogenase were purchased from Applied Biosystems Inc. qRT-PCR was performed using Bio-Rad iQ5 Real-Time Detection System (Bio-Rad). The gene expression DCT values of mRNAs from each sample were calculated by normalizing with internal control, glyceraldehyde 3-phosphate dehydrogenase and relative quantization values were plotted using Graphpad Prism (San Diego, CA, USA). Real-time qRT-PCR analysis was performed on the experimental mRNAs in triplicate, and the experiment was repeated once from an independent passage to confirm the findings.
Melanoma specimen study
The Tissue Scan Melanoma qPCR Array containing cDNAs from normal skin, stage III and stage IV melanomas was obtained from Origene Technologies (Rockville, MD, USA) and assessed for OPN and DNAJB6 transcript levels by qRT-PCR. Data were normalized to b-actin.
3D culture 3D cultures were grown following the protocol by Debnath et al. (2003) . Briefly, eight well-chambered coverglass slides DNAJB6 multiprotein complex with GSK3b regulates OPN A Mitra et al (Thermo Scientific, Waltham, MA, USA) were placed on ice and coated with 50 ml of 3D Culture Matrix Basement Membrane Extract Reduced Growth Factor (phenol red free) from Trevigen (Gaithersburg, MD, USA). The slide was incubated for 30 min in 37 1C incubator. Cells (5000/well) were plated in growth media containing 2% reduced growth factor basement membrane extract (Trevigen). Human recombinant OPN (100 ng/ml) (R&D Systems, Minneapolis, MN, USA) was supplemented for DJ þ OPNi cells. Media was changed every 4 days and the slide was viewed and photographed using a Nikon microscope (Nikon, Tokyo, Japan) using the Â 20 objective.
Size exclusion chromatography (fast protein liquid chromatography (FPLC)) Cells grown as monolayers were lysed in NP-40 lysis buffer. The clear lysate (1 ml) was separated using Superose 6 HR 10/ 30 size exclusion column (Amersham Biosciences, Piscataway, NJ, USA) as described previously (Clark et al., 2008) . Phosphate-buffered saline was used for elution, at a flow rate of 0.2 ml/min. Fractions (1 ml) were collected and analyzed by immunoblotting.
Mammalian two hybrid
CheckMate/Flexi Vector System (Promega Corp.) was used to study protein-protein interaction. In brief, COS7 cells were maintained in 5% FBS-DMEM, seeded into 96-well plates 18 h before transfection. The various DNAs, pACT-DNAJB6, pACT-DNAJB6-DJ, pACT-HSPA8, pBIND-HSPA8, pBIND-GSK3b or pBIND-vector and pGL4.31-luciferase reporter were combined in the molar ratio (1:1:2). Lipofectamine 2000 (Invitrogen) was used as transfection reagent as per the manufacturer's recommendations.
Luciferase assay
Cells were transfected using Lipofectamine 2000 (Invitrogen) as per the manufacturer's instructions. Total protein was harvested and luciferase activity measured using a Turner 20/ 20 luminometer (Turner Biosystems, Sunnyvale, CA, USA). The luciferase reading was normalized to the total protein concentration. Data are expressed as relative luciferase activity.
Tumor growth and metastasis Cells (10 7 /ml) were injected into exposed axillary mammary fat pads of 6-week-old, female athymic mice (Harlan-SpragueDawley, Indianapolis, IN, USA). Tumor size was measured weekly and mean tumor diameter was calculated as previously reported (Fillmore et al., 2009) . For monitoring metastatic spread, tumors were surgically removed under aseptic conditions under anesthesia. After a period of about 6 weeks, mice were euthanized; lungs were removed, rinsed with phosphatebuffered saline and fixed in diluted Bouin's solution (20% Bouin's fixative in neutral buffered formalin) before quantification of surface metastasis. Eight mice were used per group and each experiment was repeated once. Animals were maintained under the guidelines of the National Institutes of Health and Institutional Animal Care and Use Committee of the University of South Alabama, Mobile. Food and water were provided ad libitum.
Statistics
Statistical analyses were performed using GraphPad Prism 4 (San Diego, CA, USA). Student's t-test, Mann-Whitney, oneway analysis of variance or two-way analysis of variance was applied based on the statistical mandates or suggestions of each analysis.
